Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 366 | 3509 | 28.0 | 68% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1726 | 6069 | BEHCETS DISEASE//ORAL LICHEN PLANUS//BEHCETS SYNDROME |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BEHCETS DISEASE | Author keyword | 1892 | 73% | 41% | 1431 |
| 2 | BEHCETS SYNDROME | Author keyword | 205 | 71% | 5% | 167 |
| 3 | NEURO BEHCETS DISEASE | Author keyword | 185 | 89% | 2% | 83 |
| 4 | BEHCET DISEASE | Author keyword | 152 | 61% | 5% | 161 |
| 5 | BEHCETS DIS UNIT | Address | 82 | 92% | 1% | 33 |
| 6 | BEHCET SYNDROME | Author keyword | 79 | 72% | 2% | 62 |
| 7 | HLA B51 | Author keyword | 67 | 72% | 1% | 52 |
| 8 | INTESTINAL BEHCETS DISEASE | Author keyword | 56 | 80% | 1% | 35 |
| 9 | NEURO BEHCET | Author keyword | 51 | 83% | 1% | 29 |
| 10 | ADAMANTIADES BEHCETS DISEASE | Author keyword | 41 | 85% | 1% | 22 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BEHCETS DISEASE | 1892 | 73% | 41% | 1431 | Search BEHCETS+DISEASE | Search BEHCETS+DISEASE |
| 2 | BEHCETS SYNDROME | 205 | 71% | 5% | 167 | Search BEHCETS+SYNDROME | Search BEHCETS+SYNDROME |
| 3 | NEURO BEHCETS DISEASE | 185 | 89% | 2% | 83 | Search NEURO+BEHCETS+DISEASE | Search NEURO+BEHCETS+DISEASE |
| 4 | BEHCET DISEASE | 152 | 61% | 5% | 161 | Search BEHCET+DISEASE | Search BEHCET+DISEASE |
| 5 | BEHCET SYNDROME | 79 | 72% | 2% | 62 | Search BEHCET+SYNDROME | Search BEHCET+SYNDROME |
| 6 | HLA B51 | 67 | 72% | 1% | 52 | Search HLA+B51 | Search HLA+B51 |
| 7 | INTESTINAL BEHCETS DISEASE | 56 | 80% | 1% | 35 | Search INTESTINAL+BEHCETS+DISEASE | Search INTESTINAL+BEHCETS+DISEASE |
| 8 | NEURO BEHCET | 51 | 83% | 1% | 29 | Search NEURO+BEHCET | Search NEURO+BEHCET |
| 9 | ADAMANTIADES BEHCETS DISEASE | 41 | 85% | 1% | 22 | Search ADAMANTIADES+BEHCETS+DISEASE | Search ADAMANTIADES+BEHCETS+DISEASE |
| 10 | NEURO BEHCET DISEASE | 25 | 77% | 0% | 17 | Search NEURO+BEHCET+DISEASE | Search NEURO+BEHCET+DISEASE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | VASCULAR INVOLVEMENT | 109 | 58% | 4% | 124 |
| 2 | NEUROLOGICAL INVOLVEMENT | 100 | 63% | 3% | 102 |
| 3 | HLA B51 | 72 | 69% | 2% | 61 |
| 4 | THROMBOPHILIC FACTORS | 67 | 87% | 1% | 33 |
| 5 | RECURRENT ORAL ULCERS | 65 | 93% | 1% | 25 |
| 6 | DAGGER ETS DISEASE | 53 | 95% | 1% | 18 |
| 7 | HLA B ASTERISK 5101 | 51 | 91% | 1% | 21 |
| 8 | PATHERGY TEST | 51 | 91% | 1% | 21 |
| 9 | IL23R IL12RB2 | 44 | 63% | 1% | 45 |
| 10 | PULMONARY ARTERY ANEURYSMS | 44 | 85% | 1% | 23 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behcet's disease | 2015 | 7 | 96 | 49% |
| Current concepts - Behcet's disease | 1999 | 828 | 28 | 100% |
| Neuro-Behcet's disease: epidemiology, clinical characteristics, and management | 2009 | 107 | 114 | 96% |
| EULAR recommendations for the management of Behcet disease | 2008 | 195 | 93 | 86% |
| Anti-TNF Agents for Behcet's Disease: Analysis of Published Data on 369 Patients | 2011 | 89 | 61 | 77% |
| Behcet's disease - a contemporary review | 2009 | 82 | 106 | 92% |
| Management of Behcet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet disease | 2009 | 64 | 73 | 90% |
| Behcet's syndrome: disease manifestations, management, and advances in treatment | 2007 | 106 | 52 | 96% |
| Outcome Measures Used in Clinical Trials for Behcet Syndrome: A Systematic Review | 2014 | 6 | 225 | 84% |
| New insights into the pathogenesis of Behcet's disease | 2012 | 43 | 255 | 83% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BEHCETS DIS UNIT | 82 | 92% | 0.9% | 33 |
| 2 | BEHCETS SYNDROME | 38 | 93% | 0.4% | 14 |
| 3 | MOL MED SCI MOL MED | 7 | 53% | 0.3% | 9 |
| 4 | BEHCETS UNIT | 6 | 71% | 0.1% | 5 |
| 5 | INTERNAL MED HEMATOL ONCOL IMMUNOL RHEUMATOL | 5 | 63% | 0.1% | 5 |
| 6 | HOMEOSTASIS CELL DYSFUNCT UNIT 99 UR 08 40 | 5 | 55% | 0.2% | 6 |
| 7 | BEHCET | 3 | 100% | 0.1% | 3 |
| 8 | BEHCETS | 3 | 100% | 0.1% | 3 |
| 9 | OCULAR INFLAMMAT IMMUNOL | 3 | 25% | 0.3% | 11 |
| 10 | CHONGQING EYE | 3 | 23% | 0.3% | 12 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000102370 | RECURRENT APHTHOUS STOMATITIS//RECURRENT APHTHOUS ULCERS//RECURRENT APHTHOUS ULCERATIONS |
| 2 | 0.0000067603 | UVEITIS//PARS PLANITIS//OCULAR IMMUNOLOGY AND INFLAMMATION |
| 3 | 0.0000033292 | VOGT KOYANAGI HARADA DISEASE//VOGT KOYANAGI HARADA SYNDROME//SYMPATHETIC OPHTHALMIA |
| 4 | 0.0000030686 | EXPERIMENTAL AUTOIMMUNE UVEORETINITIS//ENDOTOXIN INDUCED UVEITIS//EXPERIMENTAL AUTOIMMUNE UVEITIS |
| 5 | 0.0000027587 | ENTEROCOLIC LYMPHOCYTIC PHLEBITIS//PHLEBOSCLEROTIC COLITIS//LYMPHOCYTIC PHLEBITIS |
| 6 | 0.0000025365 | PULMONARY ARTERY RUPTURE//PULMONARY ARTERY DISSECTION//PULMONARY ARTERY ANEURYSM |
| 7 | 0.0000021816 | RELAPSING POLYCHONDRITIS//POLYCHONDRITIS RELAPSING//AURICULAR CHONDRITIS |
| 8 | 0.0000019449 | FAMILIAL MEDITERRANEAN FEVER//MEFV//MEFV GENE |
| 9 | 0.0000019428 | ANTI ENDOTHELIAL CELL ANTIBODIES//ANTI ENDOTHELIAL CELL ANTIBODY//ANTIENDOTHELIAL CELL ANTIBODIES |
| 10 | 0.0000018635 | REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME//THUNDERCLAP HEADACHE//CALL FLEMING SYNDROME |